Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.5B | 8.2B | 7.4B | 8.2B |
| Cost of revenue | 3.7B | 4.0B | 3.5B | 4.1B |
| Gross profit | 3.8B | 4.3B | 3.9B | 4.0B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | 1.8B | 2.3B | 2.1B | 2.1B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 897M | 889M | 871M | 872M |
| Other income expense | 205M | 149M | 36M | 193M |
| Pretax income | 1.1B | 1.6B | 1.3B | 1.5B |
| Tax provision | 119M | 193M | 109M | 163M |
| Net income | 1.0B | 1.4B | 1.2B | 1.3B |
| Basic EPS | 1.3 | 1.8 | 1.5 | 1.6 |
| Diluted EPS | 1.3 | 1.8 | 1.5 | 1.6 |
| Basic average shares | 777M | 777M | 773M | 772M |
| Diluted average shares | 777M | 777M | 773M | 773M |
| EBITDA | 4.0B | 4.2B | 3.6B | 4.0B |
| Net income from continuing op. | 1.0B | 1.4B | 1.2B | 1.3B |
| Minority interests | -23M | -25M | -22M | -34M |
| Preferred stock dividends | — | — | 0 | 16M |